| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 2 | TACROLIMUS OINTMENT 0.1% | 16 |
| 3 | MYCOPHENOLATE MOFETIL | 14 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 14 |
| 5 | METHYLPREDNISOLONE | 9 |
| 6 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 |
| 7 | VALGANCICLOVIR | 9 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE | 9 |
| 9 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 1 | ENTRECTINIB | 1 | 0.0006 |
| 2 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 3 | VALGANCICLOVIR | 9 | 0.0005 |
| 4 | DACTINOMYCIN | 1 | 0.0005 |
| 5 | REGORAFENIB | 5 | 0.0004 |
| 6 | BASILIXIMAB | 5 | 0.0004 |
| 7 | EVEROLIMUS TABLETS | 5 | 0.0003 |
| 8 | IFOSFAMIDE FOR INJECTION | 5 | 0.0002 |
| 9 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 1 | 0.0005 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 3 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |